| Sequence of Radiation Therapy and Chemotherapy as Adjuvant Treatment in Breast Cancer. HN ABDEL-HALIM ABU-HAMAR, ASHRAF BARAKAT, MAHMOUD ELGANTIRY Journal of the Egyptian Nat. Cancer Inst 22 (1), 95-104, 2010 | 10 | 2010 |
| Poor survival outcome of docetaxel every three weeks plus prednisone for treatment of patients with hormone-refractory metastatic prostate cancer. ESAM Abd El Halim Abu-Hamar,Saleh Mansour, Mohamed El Shebiney, Naser Abd El ... Hematol Oncol Stem Cel Ther 3 (3), 121-127, 2010 | 4 | 2010 |
| Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool H Shawky, I Ibrahim, AK Hanan European Respiratory Journal 40 (Suppl 56), 2012 | | 2012 |
| Pilot Study of Gemcitabine and Epirubicin Combination Chemotherapy as a Salvage Regimen for Recurrent Platinum Resistant and/or Refractory Epithelial Ovarian Cancer AEH Abu-Hamar Journal of Cancer Therapy 2 (4), 490-496, 2011 | | 2011 |
| Treatment Outcome And Prognostic Factors Of Primary Localized Diffuse Large B-Cell Lymphoma Of The Stomach: A Retrospective Study AEH Abu-Hamar Accepted for publication at Journal of Cancer Therapy, 2011 | | 2011 |
| Clinicopathological Significance and Prognostic Importance of Circulating Plasma DNA Expression in Advanced Non-Small Cell Lung Cancer and Its Efficacy As A Diagnostic Tool AEH Abu-Hamar, H Shawky, AAKHS Ibrahim. S. Ibrahim Life Science Journal 8 (4), 143-150, 2011 | | 2011 |
| A Phase II Single Institution Study of Docetaxel in Patients with Recurrent and/or Metastatic Non-Nasopharyn-geal Squamous Cell Carcinoma of the Head and Neck Refractory to a … MALME HANAN SHAWKY, ABDEL HALIM ABO HAMAR Nature and Science Journal 8 (11), 267-274, 2010 | | 2010 |
| Weekly Cisplatin and Docetaxel plus Concomitant Boost Concurrently with Radiation Therapy in the Treatment of Locally Advanced Head and Neck Cancer: Phase II Trial RM Abd El Halim Abu-Hamar, Naser Abd El Bary, Mostafa El Haddad Pan Arab Journal of Oncology 3 (3), 26-30, 2010 | | 2010 |
| Three Weekly Docetaxel plus Predinsolone for Patients with Hormone-Refractory Metastatic Prostate Cancer: Preliminary Result M Abd El Halim, S Mansour, MM El Shebiney, NM Abd El Barny, ... Journal of Men's Health 3 (7), 295-296, 2010 | | 2010 |
| THREE-WEEKLY DOCETAXEL WITH PREDNISOLONE FOR PATIENTS WITH HORMONE-REFRACTORY METASTATIC PROSTATE CANCER: PRELIMINARY RESULTS AEH Abu-Hamar, S Mansour, M El Shebiney, N Abd El Bary, E Sadaka, ... Research in Oncology 5 (3-4), 31-37, 2009 | | 2009 |
| Prognostic Significance Of PSA, Gleason Score, Bone Metastases In Patients With Metastatic Prostate Cancer Under Palliative Androgen Deprivation Treatment. AHABUHANDT GAMIL Journal of the Egyptian National Cancer Institute 21 (3), 229-236, 2009 | | 2009 |
| 2. The outcomes of concomitant Radiation plus Temozolomide followed by Adjuvant Temozolomide for Newly Diagnosed High Grade Gliomas: The Preliminary Results of single center … H SHAWKY, AHABO HAMAR, DELS SAMAR GALAL, FATMA ZAKARIA Journal of the Egyptian National Cancer Institute 21 (2), 107-119, 2009 | | 2009 |
| 1. Locally Advanced Pancreatic Cancer : 6 Years Experience of 5-Fluorouracil-Based Chemoradiation Versus Gemcitabine-Based Chemoradiation HE Shazly, EA Zeina, H SHAWKY, F ZAKARIA, AHABO HAMAR, ... The Medical Journal of Cairo University 75 (3), 139-149, 2007 | | 2007 |
| Poor survival outcome of docetaxel every three weeks plus prednisone for treatment of patients with hormone-refractory metastatic prostate cancer ES El Bary, A Maria | | |
